Methods for treating ulcers in thalassemia syndrome with an ActRIIB polypeptide
US-9850298-B2 · Dec 26, 2017 · US
This page is not indexed by search engines while we improve data quality.
Acceleron Pharma Inc patents in 2017
Acceleron Pharma Inc was listed as an assignee on 29 patent publications in 2017.
| Metric | Value |
|---|---|
| Company | Acceleron Pharma Inc |
| Year | 2017 |
| Patents | 29 |
Patents
Representative publications for Acceleron Pharma Inc in 2017.
Methods for treating ulcers in thalassemia syndrome with an ActRIIB polypeptide
US-9850298-B2 · Dec 26, 2017 · US
Activin-actrii antagonists and uses for treating anemia
US-2017360887-A1 · Dec 21, 2017 · US
Alk1 receptor and ligand antagonists and uses thereof
US-2017354731-A1 · Dec 14, 2017 · US
Methods and compositions for treating ineffective erythropoiesis
US-2017327800-A1 · Nov 16, 2017 · US
Top CPC classifications
Most common classification codes for Acceleron Pharma Inc in 2017.
| CPC | Patents |
|---|---|
| C07K2319/30 | 22 |
| C07K14/71 | 20 |
| A61P35/00 | 18 |
| A61K38/179 | 15 |
| A61K38/00 | 14 |
Related pages
Navigate to parent entity pages.